Additionally, along with further exploration, researchers found that WFDC2 presented a high expression state in lung cancer (55–58) and recognized that WFDC2 as a serum tumor marker had important clinical application in the early diagnosis of lung cancer and the monitoring of a curative effect (59). This evidence concerns the gene WFDC2 and lung carcinoma.